- Home
- Publications
- Publication Search
- Publication Details
Title
A Review of Causal Inference for External Comparator Arm Studies
Authors
Keywords
-
Journal
DRUG SAFETY
Volume 45, Issue 8, Pages 815-837
Publisher
Springer Science and Business Media LLC
Online
2022-07-27
DOI
10.1007/s40264-022-01206-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- External Control Arms in Oncology: Current Use and Future Directions
- (2022) P.S. Mishra-Kalyani et al. ANNALS OF ONCOLOGY
- Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer
- (2022) Xiang Yin et al. Journal of Biopharmaceutical Statistics
- Estimands in observational studies: Some considerations beyond ICH E9 ( R1 )
- (2022) Heng Li et al. PHARMACEUTICAL STATISTICS
- Virtual controls as an alternative to randomized controlled trials for assessing efficacy of interventions
- (2021) Joseph M. Strayhorn BMC Medical Research Methodology
- Implementing Historical Controls in Oncology Trials
- (2021) Olivier Collignon et al. ONCOLOGIST
- Principal stratum strategy: Potential role in drug development
- (2021) Björn Bornkamp et al. PHARMACEUTICAL STATISTICS
- Estimands in hematologic oncology trials
- (2021) Steven Sun et al. PHARMACEUTICAL STATISTICS
- The use of external controls: To what extent can it currently be recommended?
- (2021) Hans Ulrich Burger et al. PHARMACEUTICAL STATISTICS
- The Use of External Controls in FDA Regulatory Decision Making
- (2021) Mahta Jahanshahi et al. Therapeutic Innovation & Regulatory Science
- Multiple imputation confidence intervals for the mean of the discrete distributions for incomplete data
- (2021) Chung‐Han Lee et al. STATISTICS IN MEDICINE
- The Magic of Randomization versus the Myth of Real-World Evidence
- (2020) Rory Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variance estimation when using propensity‐score matching with replacement with survival or time‐to‐event outcomes
- (2020) Peter C. Austin et al. STATISTICS IN MEDICINE
- When Context Is Hard to Come By: External Comparators and How to Use Them
- (2020) Christina Mack et al. Therapeutic Innovation & Regulatory Science
- A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World Data
- (2020) Christen M. Gray et al. DRUG SAFETY
- Overlap Weighting
- (2020) Laine E. Thomas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A roadmap to using historical controls in clinical trials – by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG)
- (2020) Mercedeh Ghadessi et al. Orphanet Journal of Rare Diseases
- Real‐world evidence to support regulatory decision‐making for medicines: Considerations for external control arms
- (2020) Mehmet Burcu et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Performance of propensity score matching to estimate causal effects in small samples
- (2020) Anais Andrillon et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Advances in propensity score analysis
- (2020) Peter C Austin STATISTICAL METHODS IN MEDICAL RESEARCH
- Synthetic and External Controls in Clinical Trials – A Primer for Researchers
- (2020) Kristian Thorlund et al. Clinical Epidemiology
- Variance estimation in inverse probability weighted Cox models
- (2020) Di Shu et al. BIOMETRICS
- Robust estimation of causal effects via a high-dimensional covariate balancing propensity score
- (2020) Yang Ning et al. BIOMETRIKA
- Use of real‐world data to emulate a clinical trial and support regulatory decision‐making: assessing the impact of temporality, comparator choice and methods of adjustment
- (2020) Devin Abrahami et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Designing historical control studies with survival endpoints using exact statistical inference
- (2020) Gang Han PHARMACEUTICAL STATISTICS
- Summarising salient information on historical controls: A structured assessment of validity and comparability across studies
- (2020) Anthony Hatswell et al. Clinical Trials
- Single-arm trials with historical controls
- (2020) Samy Suissa EPIDEMIOLOGY
- Methods for external control groups for single arm trials or long‐term uncontrolled extensions to randomized clinical trials
- (2020) John D. Seeger et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Evaluating the Use of Nonrandomized Real World Data Analyses for Regulatory Decision Making
- (2019) Jessica M. Franklin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Characteristics of non-randomised studies using comparisons with external controls submitted for regulatory approval in the USA and Europe: a systematic review
- (2019) Sarah Goring et al. BMJ Open
- Creating historical controls using data from a previous line of treatment – Two non-standard approaches
- (2019) Anthony J Hatswell et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- An evaluation of the impact of missing deaths on overall survival analyses of advanced non–small cell lung cancer patients conducted in an electronic health records database
- (2019) Gillis Carrigan et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The proportion of missing data should not be used to guide decisions on multiple imputation
- (2019) Paul Madley-Dowd et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The seven tools of causal inference, with reflections on machine learning
- (2019) Judea Pearl COMMUNICATIONS OF THE ACM
- Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer
- (2019) Sandra D. Griffith et al. ADVANCES IN THERAPY
- Effect estimates in randomized trials and observational studies: comparing apples with apples
- (2019) Sara Lodi et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
- (2019) Alison Cave et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Structured Pre‐ and Post‐Approval Comparative Study Design Framework to Generate Valid and Transparent Real‐World Evidence for Regulatory Decisions
- (2019) Nicolle M Gatto et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Propensity score analysis for correlated subgroup effects
- (2019) Shan-Yu Liu et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data
- (2019) Steffen Ventz et al. CLINICAL CANCER RESEARCH
- Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proof‐of‐Concept in Randomized Controlled Trials
- (2019) Gillis Carrigan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Nonrandomized real‐world evidence to support regulatory decision‐making: Process for a randomized trial replication project
- (2019) Jessica M. Franklin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Guide to Conducting a Meta-Analysis with Non-Independent Effect Sizes
- (2019) Mike W.-L. Cheung NEUROPSYCHOLOGY REVIEW
- Oncology phase II proof‐of‐concept studies with multiple targets: Randomized controlled trial or single arm?
- (2019) Thomas Jemielita et al. PHARMACEUTICAL STATISTICS
- Subgroup balancing propensity score
- (2019) Jing Dong et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Minimal dispersion approximately balancing weights: asymptotic properties and practical considerations
- (2019) Yixin Wang et al. BIOMETRIKA
- Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation
- (2019) Hans‐Georg Eichler et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Beyond Randomized Clinical Trials: Use of External Controls
- (2019) Heinz Schmidli et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Trial designs using real‐world data: The changing landscape of the regulatory approval process
- (2019) Elodie Baumfeld Andre et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Relative Performance of Propensity Score Matching Strategies for Subgroup Analyses
- (2018) Shirley V Wang et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Covariate association eliminating weights: a unified weighting framework for causal effect estimation
- (2018) Sean Yiu et al. BIOMETRIKA
- The use of real-world data in cancer drug development
- (2018) E. Skovlund et al. EUROPEAN JOURNAL OF CANCER
- The Future of Precision Medicine: Potential Impacts for Health Technology Assessment
- (2018) James Love-Koh et al. PHARMACOECONOMICS
- On the propensity score weighting analysis with survival outcome: Estimands, estimation, and inference
- (2018) Huzhang Mao et al. STATISTICS IN MEDICINE
- Advancing a Framework for Regulatory Use of Real-World Evidence
- (2018) Nancy A. Dreyer Therapeutic Innovation & Regulatory Science
- Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials
- (2018) Jessica Lim et al. Therapeutic Innovation & Regulatory Science
- Comparative effectiveness from a single-arm trial and real-world data: alectinib versus ceritinib
- (2018) Jessica Davies et al. Journal of Comparative Effectiveness Research
- OUP accepted manuscript
- (2018) AMERICAN JOURNAL OF EPIDEMIOLOGY
- Closed-form variance estimator for weighted propensity score estimators with survival outcome
- (2018) David Hajage et al. BIOMETRICAL JOURNAL
- Subgroup identification in clinical trials via the predicted individual treatment effect
- (2018) Nicolás M. Ballarini et al. PLoS One
- Treatment effect quantification for time-to-event endpoints-Estimands, analysis strategies, and beyond
- (2018) Kaspar Rufibach PHARMACEUTICAL STATISTICS
- Considerations in characterizing real‐world data relevance and quality for regulatory purposes: A commentary
- (2018) Cynthia J. Girman et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Comparison of Propensity Score Methods and Covariate Adjustment
- (2017) Markus C. Elze et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Differences Between Conditional and Marginal Propensity Score Estimates
- (2017) Michelle Samuel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Balancing Covariates via Propensity Score Weighting
- (2017) Fan Li et al. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
- Real-world Data for Clinical Evidence Generation in Oncology
- (2017) Sean Khozin et al. JNCI-Journal of the National Cancer Institute
- A plea to provide best evidence in trials under sample-size restrictions: the example of pioglitazone to resolve leukoplakia and erythroplakia in Fanconi anemia patients
- (2017) Florian Lasch et al. Orphanet Journal of Rare Diseases
- Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making
- (2017) Marc L. Berger et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Including historical data in the analysis of clinical trials: Is it worth the effort?
- (2017) Joost van Rosmalen et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Propensity score analysis with partially observed covariates: How should multiple imputation be used?
- (2017) Clémence Leyrat et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Causal inference in survival analysis using pseudo-observations
- (2017) Per K. Andersen et al. STATISTICS IN MEDICINE
- Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies
- (2017) Amr Makady et al. VALUE IN HEALTH
- Real-world Data for Clinical Evidence Generation in Oncology
- (2017) Sean Khozin et al. JNCI-Journal of the National Cancer Institute
- Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.
- (2016) Miguel A. Hernán et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Quantitative Bias Analysis in Regulatory Settings
- (2016) Timothy L. Lash et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- “Threshold-crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?
- (2016) H-G Eichler et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- RECIST 1.1—Update and clarification: From the RECIST committee
- (2016) Lawrence H. Schwartz et al. EUROPEAN JOURNAL OF CANCER
- Comparison of Eligibility Criteria Between Protocols, Registries, and Publications of Cancer Clinical Trials
- (2016) Sheng Zhang et al. JNCI-Journal of the National Cancer Institute
- The performance of different propensity score methods for estimating absolute effects of treatments on survival outcomes: A simulation study
- (2016) Peter C Austin et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis
- (2016) Peter C. Austin STATISTICS IN MEDICINE
- Tutorial in biostatistics: data-driven subgroup identification and analysis in clinical trials
- (2016) Ilya Lipkovich et al. STATISTICS IN MEDICINE
- Comparison of Eligibility Criteria Between Protocols, Registries, and Publications of Cancer Clinical Trials
- (2016) Sheng Zhang et al. JNCI-Journal of the National Cancer Institute
- The GRACE Checklist: A Validated Assessment Tool for High Quality Observational Studies of Comparative Effectiveness
- (2016) Nancy A. Dreyer et al. Journal of Managed Care & Specialty Pharmacy
- The role of nonrandomized trials in the evaluation of oncology drugs
- (2015) R Simon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Sample size considerations for historical control studies with survival outcomes
- (2015) Hong Zhu et al. Journal of Biopharmaceutical Statistics
- Stable Weights that Balance Covariates for Estimation With Incomplete Outcome Data
- (2015) José R. Zubizarreta JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
- Globally efficient non-parametric inference of average treatment effects by empirical balancing calibration weighting
- (2015) Kwun Chuen Gary Chan et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY
- Does Cox analysis of a randomized survival study yield a causal treatment effect?
- (2015) Odd O. Aalen et al. LIFETIME DATA ANALYSIS
- Do single-arm trials have a role in drug development plans incorporating randomised trials?
- (2015) Michael J. Grayling et al. PHARMACEUTICAL STATISTICS
- Optimal full matching for survival outcomes: a method that merits more widespread use
- (2015) Peter C. Austin et al. STATISTICS IN MEDICINE
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
- (2015) Peter C. Austin et al. STATISTICS IN MEDICINE
- Good practices for quantitative bias analysis
- (2014) T. L. Lash et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Instrumental variable methods for causal inference
- (2014) Michael Baiocchi et al. STATISTICS IN MEDICINE
- Sample size calculation for studies comparing binary outcomes using historical controls
- (2013) Song Zhang et al. BIOMETRICAL JOURNAL
- Predicting the restricted mean event time with the subject's baseline covariates in survival analysis
- (2013) L. Tian et al. BIOSTATISTICS
- Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
- (2013) Patrick Royston et al. BMC Medical Research Methodology
- Covariate balancing propensity score
- (2013) Kosuke Imai et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY
- Assessing the Impact of Propensity Score Estimation and Implementation on Covariate Balance and Confounding Control Within and Across Important Subgroups in Comparative Effectiveness Research
- (2013) Cynthia J. Girman et al. MEDICAL CARE
- A tutorial on propensity score estimation for multiple treatments using generalized boosted models
- (2013) Daniel F. McCaffrey et al. STATISTICS IN MEDICINE
- The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments
- (2013) Peter C. Austin STATISTICS IN MEDICINE
- Caution should be used in applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses: commentary on “Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses”
- (2012) Sue M. Marcus et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A comparison of two methods of estimating propensity scores after multiple imputation
- (2012) Robin Mitra et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Estimation of treatment effect under non-proportional hazards and conditionally independent censoring
- (2012) Adam P. Boyd et al. STATISTICS IN MEDICINE
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
- Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses
- (2011) Jeremy A. Rassen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Statistical Criteria for Selecting the Optimal Number of Untreated Subjects Matched to Each Treated Subject When Using Many-to-One Matching on the Propensity Score
- (2010) Peter C. Austin AMERICAN JOURNAL OF EPIDEMIOLOGY
- Calculating sample size in trials using historical controls
- (2010) Song Zhang et al. Clinical Trials
- Matching Methods for Causal Inference: A Review and a Look Forward
- (2010) Elizabeth A. Stuart STATISTICAL SCIENCE
- Treatment–subgroup interaction: An example from a published, phase II clinical trial
- (2009) Carolyn E. Behrendt et al. Contemporary Clinical Trials
- For objective causal inference, design trumps analysis
- (2008) Donald B. Rubin Annals of Applied Statistics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More